← Back to headlines
Eli Lilly's Weight-Loss Drugs Value to Investors
The financial value of Eli Lilly's weight-loss drugs to investors is being assessed, highlighting their potential impact on the company's market performance.
13 Jul, 08:43 — 13 Jul, 08:43
Sources
Showing 1 of 1 sources
